Your browser doesn't support javascript.
loading
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid, Marius; Arribas, José R; Assoumou, Lambert; Holten, Aleksander Rygh; Poissy, Julien; Terzic, Vida; Mazzaferri, Fulvia; Baño, Jesús Rodríguez; Eustace, Joe; Hites, Maya; Joannidis, Michael; Paiva, José-Artur; Reuter, Jean; Püntmann, Isabel; Patrick-Brown, Thale D J H; Westerheim, Elin; Nezvalova-Henriksen, Katerina; Beniguel, Lydie; Dahl, Tuva Børresdatter; Bouscambert, Maude; Halanova, Monika; Péterfi, Zoltán; Tsiodras, Sotirios; Rezek, Michael; Briel, Matthias; Ünal, Serhat; Schlegel, Martin; Ader, Florence; Lacombe, Karine; Amdal, Cecilie Delphin; Rodrigues, Serge; Tonby, Kristian; Gaudet, Alexandre; Heggelund, Lars; Mootien, Joy; Johannessen, Asgeir; Møller, Jannicke Horjen; Pollan, Beatriz Diaz; Tveita, Anders Aune; Kildal, Anders Benjamin; Richard, Jean-Christophe; Dalgard, Olav; Simensen, Victoria Charlotte; Baldé, Aliou; de Gastines, Lucie; Del Álamo, Marta; Aydin, Burç; Lund-Johansen, Fridtjof; Trabaud, Mary-Anne; Diallo, Alpha.
Afiliação
  • Trøseid M; Section for Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway. marius.troseid@medisin.uio.no.
  • Arribas JR; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. marius.troseid@medisin.uio.no.
  • Assoumou L; Infectious Diseases Unit, Internal Medicine Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.
  • Holten AR; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
  • Poissy J; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie Et de Santé Publique (IPLESP), Paris, France.
  • Terzic V; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Mazzaferri F; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
  • Baño JR; Lille University, Lille, France/CHU Lille - Hôpital Roger Salengro, Lille, France.
  • Eustace J; L'Institut National de La Santé Et de La Recherche Médicale (Inserm), Paris, France.
  • Hites M; Maladies Infectieuses Emergentes, 75015, Paris, France.
  • Joannidis M; Institut National de La Santé Et de La Recherche Médicale, INSERM, 75013, Paris, France.
  • Paiva JA; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Reuter J; Department of Medicine, Virgen Macarena University Hospital, Seville, Spain.
  • Püntmann I; University of Sevilla and Biomedicines Institute of Seville (IBiS)/CSIC, Seville, Spain.
  • Patrick-Brown TDJH; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
  • Westerheim E; University College Cork, Cork, Ireland.
  • Nezvalova-Henriksen K; Brussels University Hospital-Erasme, Brussels, Belgium.
  • Beniguel L; Université Libre de Bruxelles, Brussels, Belgium.
  • Dahl TB; Medical University Innsbruck, Innsbruck, Austria.
  • Bouscambert M; Intensive Care Medicine Department, Centro Hospitalar Universitário Sao Joao, Porto, Portugal.
  • Halanova M; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Péterfi Z; Centre Hospitalier de Luxembourg, Service de Réanimation-Soins Intensifs, 1210, Luxembourg, Luxembourg.
  • Tsiodras S; Institute of Pharmacology, Hospital Group Gesundheit Nord gGmbH, Bremen, Germany.
  • Rezek M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Briel M; Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Oslo, Norway.
  • Ünal S; Section for Monitoring, Clinical Trial Unit (CTU), Oslo University Hospital, Oslo, Norway.
  • Schlegel M; Department of Haematology, Oslo University Hospital and Oslo Hospital Pharmacy, Oslo, Norway.
  • Ader F; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie Et de Santé Publique (IPLESP), Paris, France.
  • Lacombe K; Research Institute for Internal Medicine, Oslo University Hospital, Oslo, Norway.
  • Amdal CD; Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
  • Rodrigues S; Laboratoire de Virologie, Institut Des Agents Infectieux de Lyon, Centre National de Reference Des Virus Des Infections Respiratoires France Sud, Hospices Civils de Lyon, 69317, Lyon, France.
  • Tonby K; Department of Epidemiology, Faculty of Medicine, Pavol Jozef Safárik University in Kosice, Kosice, Slovakia.
  • Gaudet A; 1St Department of Internal Medicine, Division of Infectology, University of Pécs, Pécs, Hungary.
  • Heggelund L; National and Kapodistrian University of Athens, Athens, Greece.
  • Mootien J; University Hospital of Athens Attikon, Athens, Greece.
  • Johannessen A; St. Anne University Hospital, Brno, Czech Republic.
  • Møller JH; Swiss Clinical Trial Organisation and Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Pollan BD; Hacettepe University Hospital, Ankara, Turkey.
  • Tveita AA; Department of Anesthesiology and Intensive Care Medicine, Klinikum Rechts Der Isar, Technische Universität München, Munich, Germany.
  • Kildal AB; Hospices Civils de Lyon, Département Des Maladies Infectieuses Et Tropicales, 69004, Lyon, France.
  • Richard JC; Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Univ Lyon, 69007, Lyon, France.
  • Dalgard O; Sorbonne Université, Institut Pierre-Louis d'Épidemiologie Et de Santé Publique, INSERM, 75013, Paris, France.
  • Simensen VC; APHP, Hôpital Saint-Antoine, Service de Maladies Infectieuses Et Tropicales, 75012, Paris, France.
  • Baldé A; Research support service and Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • de Gastines L; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie Et de Santé Publique (IPLESP), Paris, France.
  • Del Álamo M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Aydin B; Deptartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Lund-Johansen F; Critical Care Center, Department of Intensive Care Medicine, CHU Lille, 59000, Lille, France.
  • Trabaud MA; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection Et d'Immunité de Lille, 59000, Lille, France.
  • Diallo A; Medical Department, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
Crit Care ; 27(1): 9, 2023 01 10.
Article em En | MEDLINE | ID: mdl-36627655
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Crit Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Crit Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega